Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java']Java

被引:0
|
作者
Nuraini, Nuning [1 ,6 ]
Soekotjo, Fadiya Nadhilah [2 ]
Alifia, Almira [2 ]
Sukandar, Kamal Khairudin [1 ]
Lestari, Bony Wiem [3 ,4 ,5 ]
机构
[1] Inst Teknol Bandung, Dept Math, Bandung 40132, Indonesia
[2] Univ Padjadjaran, Res Ctr Care & Control Infect Dis, Bandung 40161, Indonesia
[3] Epidemiol Grp COVID 19 Task Force West Java, Bandung 40171, Indonesia
[4] Univ Padjadjaran, Fac Med, Dept Publ Hlth, Bandung 40161, Indonesia
[5] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands
[6] Bandung Inst Technol, Fac Math & Nat Sci, Dept Math, Jl Ganesha 10, Bandung 40132, Indonesia
关键词
COVID-19 booster vaccine; Mathematical modelling; Vaccine coverage;
D O I
10.1016/j.heliyon.2023.e20009
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: Primary and booster vaccinations are crucial in COVID-19 control. This study aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 cases in 2023 in Indonesia, a low-resource setting country. Methods: We used a modified SEIR compartment model to assess different scenarios in booster coverage across West Java population: 35%, 50%, and 70%. We fitted the model, then we calculated the potential active cases in 2023 if each scenario was met before 2022 ends. A heat map of predicted cases from various booster coverages and time frames was produced and matched with vaccination rate's function to determine feasible time frames. Results: A minimum of 70% booster coverage in West Java is needed to reduce 90% of potential COVID-19 cases and avert possible surge in 2023. The booster doses should be distributed before February 2023 to achieve its optimum preventive effect. Delays in achieving minimum booster coverage is acceptable, but higher booster coverage will be required. Conclusions: For better COVID-19 control in Indonesia, booster vaccination is warranted, as presented by a case study in West Java. Sufficient vaccine supplies, infrastructure, and healthcare workers should be ensured to support a successful booster vaccination program.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Analysis of SARS-CoV-2 Genomes from West Java']Java, Indonesia
    Fibriani, Azzania
    Stephanie, Rebecca
    Alfiantie, Afifah Alifia
    Siregar, Agust Leo Fany
    Pradani, Gusti Ayu Prani
    Yamahoki, Nicholas
    Purba, William Steflandel
    Alamanda, Cut Nur Cinthia
    Rahmawati, Ema
    Rachman, Rifky Waluyajati
    Robiani, Rini
    Ristandi, Ryan Bayusantika
    [J]. VIRUSES-BASEL, 2021, 13 (10):
  • [2] Implications of COVID-19 vaccine boosters amid the emergence of novel variants of SARS-CoV-2
    Dhawan, Manish
    Bin Emran, Talha
    Choudhary, Om Prakash
    [J]. ANNALS OF MEDICINE AND SURGERY, 2022, 77
  • [3] Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: an update
    Mohapatra, Ranjan K.
    El-Shall, Nahed A.
    Tiwari, Ruchi
    Nainu, Firzan
    Kandi, Venkataramana
    Sarangi, Ashish K.
    Mohammed, Teroj Abdulrahman
    Desingu, Perumal Arumugam
    Chakraborty, Chiranjib
    Dhama, Kuldeep
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [4] Enhanced neutralization of SARS-CoV-2 by a tetravalent COVID-19 vaccine booster
    Wang, Xun
    Jiang, Shujun
    Ma, Wenta
    Li, Xiangnan
    Wei, Kaifeng
    Xie, Faren
    Zhao, Chaoyue
    Zhao, Xiaoyu
    Wang, Shidi
    Li, Chen
    Qiao, Rui
    Cui, Yuchen
    Chen, Yanjia
    Li, Kaifeng Jiayan
    Cai, Guonan
    Liu, Changyi
    Yu, Jizhen
    Li, Jixi
    Hu, Zixin
    Zhang, Wenhong
    Jiang, Shibo
    Li, Mingkun
    Zhang, Yanliang
    Wang, Pengfei
    [J]. CELL HOST & MICROBE, 2024, 32 (01) : 25 - +
  • [5] The recombinant variants of SARS-CoV-2: Concerns continues amid COVID-19 pandemic
    Mohapatra, Ranjan K.
    Kandi, Venkataramana
    Tuli, Hardeep S.
    Chakraborty, Chiranjib
    Dhama, Kuldeep
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (08) : 3506 - 3508
  • [6] SARS-CoV-2 genetic variation and bacterial communities of naso- oropharyngeal samples in middle-aged and elderly COVID-19 patients in West Java']Java, Indonesia
    Adzdzakiy, Muhammad M.
    Sutarno, Sutarno
    Asyifa, Isnaini Z.
    Sativa, Alvira R.
    Fiqri, Ahmad R. A.
    Fibriani, Azzania
    Ristandi, Ryan B.
    Ningrum, Ratih A.
    Iryanto, Syam B.
    Prasetyoputri, Anggia
    Dharmayanthi, Anik B.
    Saputra, Sugiyono
    [J]. JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2024, 19 (01): : 70 - 81
  • [7] Predicting the weekly COVID-19 new cases using multilayer perceptron: An evidence from west Java']Java, Indonesia
    Hidayat, Yuyun
    Pangestu, Dhika Surya
    Subiyanto
    Purwandari, Titi
    Sukono
    Saputra, Jumadil
    [J]. DECISION SCIENCE LETTERS, 2022, 11 (03) : 247 - 262
  • [8] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    [J]. VACCINES, 2021, 9 (03) : 1 - 13
  • [9] COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants
    Yogesh, Ruchika
    Srivastava, Noopur
    Bukhari, Syed Nasir Abbas
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (35) : 2901 - 2913
  • [10] Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java']Java, Indonesia
    Megasari, Ni Luh Ayu
    Yamani, Laura Navika
    Juniastuti, Juniastuti
    Lusida, Maria Inge
    Mori, Yasuko
    [J]. PEERJ, 2023, 11